Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 22, 2024Trends in ImmunotherapyOpen Access

Role of blood hepcidin alteration as a biomarker in β-thalassemia patients’ diagnosis

View Full Paper
Ask AI
Bookmark
Share

Authors

WAWaseem Yousif M. AL-dulaimyKSKhalid Shaalan SahabEMEbtehal Sabri Mohammed

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

AL-dulaimy et al. (2024) studied this question.

synapsesocial.com/papers/68e6e1f0b6db64358765dbffhttps://doi.org/10.24294/ti.v8.i1.4397
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Estimation of Hepcidin Role and some Biochemical Parameters in Patients with Beta- thalassemia in Thi-Qar Governorate/ Iraq2024
  2. 2Comparative Analysis of the Age, Gender, and Ferritin Levels with Hepcidin in Iraqi Patients Suffering Beta Thalassemia (Major and Intermedia)2025
  3. 3Evaluation of some hormones in patients with major β-Thalassemia in the Nineveh Governorate - Iraq2024
  4. 4Association Between Serum Ferritin Level and Liver Function Tests in Children with Beta-Thalassemia (Thalassemia Center of Kut Hospital, Iraq)2024
  5. 5Status of Hepcidin and SOD in a Sample of Jordanian β-Thalassemia Patients2024